Fitness & Wellness

Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision

34 sec read5 views0 listens

Apnimed has appointed Kevin Lin as its new CEO as the company moves towards the potential commercialization of its investigational oral therapy for obstructive sleep apnea. This leadership transition is critical for developers and tech professionals as it signals a significant step towards a new treatment option entering the market, potentially impacting wearable health tech and diagnostic tool development for sleep disorders. The company's progress with its oral therapy, AD109, which has a potential FDA decision in early 2027, warrants close monitoring for future integration opportunities.

Read the full article at Sleep Review

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

A Pennsylvania federal court rejected federal preemption as a defense to terminating a medical marijuana cardholder, holding that Pennsylvania's state protections survive despite federal prohibition and that zero-tolerance policies inadequately addre...

Ali Nemati

Cybersecurity1 day ago29 sec read

AI scribes promise relief for clinicians yet Canada's experience shows the trade-offs are real

AI-powered medical scribes are being piloted in Canada to automate clinical note generation from patient-clinician conversations, aiming to reduce administrative burdens and clinician burnout. While offering efficiency gains, these tools raise concer...

Ali Nemati

Biotech & Pharma6 days ago28 sec read

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck has partnered with Protillion Biosciences to accelerate drug discovery through a collaboration potentially worth up to $510 million. This initiative leverages Protillion's AI-driven "lab-in-the-loop" platform, combining extensive wet-lab data w...

Ali Nemati

Biotech & PharmaJun 1524 sec read

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

Health & MedicineJun 1526 sec read

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada

The FDA has approved Colorado's plan to import cheaper prescription drugs from Canada, following Florida’s lead. This move aims to alleviate high drug costs for residents but faces challenges such as opposition from the Canadian pharmaceutical indust...

Ali Nemati

Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision

Related Articles

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

AI scribes promise relief for clinicians yet Canada's experience shows the trade-offs are real

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada